Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes

References

• Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 2006a;49: 660–6
   Google Scholar
• Skrivarhaug T, Bangstad HJ, Stene LC, et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49: 298–305
   PubMed Web of Science ®Google Scholar
• Asao K, Sarti C, Forsen T-cells, et al.; for the Diabetes Epidemiology Research International (DERI) Mortality Study group. Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 2003;26: 2037–42
   Google Scholar
• Nishimura R, Laporte RE, Dorman JS, et al. Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 2001;24:823–7
   Google Scholar
• Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. High risk of cardiovascular disease in patients with type 1 diabetes in the UK. A cohort study using the General Practice Research database. Diabetes Care 2006b;29: 798–804
   Google Scholar
• Pozza RD, Bechtold S, Bonfig W, et al. Age of onset of type 1 diabetes in children and carotid intima medial thickness. J Clin Endocrinol Metab 2007;92:2053–7
   PubMed Web of Science ®Google Scholar
• Pambianco G, Costacou T, Ellis D, et al. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications study experience. Diabetes 2006;55:1463–9
   PubMed Web of Science ®Google Scholar
• Nathan DM, Cleary PA, Backlund JY, et al.; for the DCCT/ EDIC Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New Engl J Med 2005;353: 2643–53
   Google Scholar
• Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002;25:134–47
   PubMed Web of Science ®Google Scholar
• Weis U, Turner B, Gibney J, et al. Long-term predictors of coronary artery disease and mortality in type 1 diabetes. QJM. 2001;94:623–30
   PubMed Web of Science ®Google Scholar
• JBS 2. Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91 (Suppl 5)
   Google Scholar
• Roche HM. Dietary carbohydrates and triacylglycerol metabolism. Proc Nutr Soc 1999;58:201–6
   PubMed Web of Science ®Google Scholar
• Schwab KO, Doerfer J, Hecker W, et al. Spectrum and prevalence of atherogenic risk factors in 27 358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006;29:218–25
   PubMed Web of Science ®Google Scholar
• Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Glycemic and risk factor control in type 1 diabetes. Diabetes Care 2007;30: 496–502
   Google Scholar
• O’Hare JP, Raymond NT, Mughal S, et al. Evaluation of delivery of enhanced diabetes care to patients of south Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabetic Medicine 2004;21:1357–65
   Google Scholar
• Dixon AD, Raymond NT, Mughal S, et al. Prevalence of microalbuminuria and hypertension in south Asians and white Europeans with type 2 diabetes: a report from the United Kingdom Asian Diabetes Study (UKADS). Diabetes Vascular Dis Res 2006;3(1):22–5
   PubMedGoogle Scholar
• Barnett AH, Dixon AN, Bellary S, et al. Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia 2006;39:2234–46
   Google Scholar
• DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993;329:977–86
   PubMed Web of Science ®Google Scholar
• McKnight JA. Assessing vascular risk in people with Type 1 diabetes: implications for the effectiveness of statin therapy. Diabetic Med 2007;24:575–8
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ Collaboration. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis to date from 90 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78
   PubMed Web of Science ®Google Scholar
• Allen KV, Walker JD. Microalbuminuria and mortality in long-duration type 1 diabetes. Diabetes Care 2003;26:2389–91
   PubMed Web of Science ®Google Scholar
• Wallymahmed ME, Pinkney J, Saunders S, et al. Vascular risk factors in patients with type 1 diabetes. Practical Diabetes Int 2005;22:81–5
   Google Scholar
• Wadwa RP, Hokanson JE, Kinney GL, et al. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 2005:28:1051–6
   PubMed Web of Science ®Google Scholar
• Maahs DM, Kinney GL, Wadwa P, et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 2005;28:301–6
   PubMed Web of Science ®Google Scholar
• Coppell KJ, Anderson K, Williams S, et al. Evaluation of diabetes care in the Otago region using a diabetes register, 1998–2003. Diabetes Res Clin Pract 2006;71:345–52
   PubMed Web of Science ®Google Scholar
• Nordwall M, Bojestig M, Arnqvist HJ, et al.; for the Linköping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes – the Linköping Diabetes Complications Study. Diabetologia 2004;47: 1266–72
   Google Scholar
• Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26:1258–64
   PubMed Web of Science ®Google Scholar